Trusted by:
A new treatment approach developed at Roswell Park Comprehensive Cancer Center has shown promising results in a phase 1 clinical trial for patients with triple-negative breast cancer (TNBC), the most aggressive type of breast cancer. Results of the study are newly reported in The Journal for ImmunoTherapy of Cancer.
Study in the Journal of Medical Internet Research introduces the EDAI framework to integrate equity, diversity, and inclusion in AI for health and oral health care.
Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the detection rate of cancer DNA in the blood.
Recent research from the University of Georgia suggests the unique stresses from farm life may be taking a toll on one of the pillars of the families that make your dinners possible: the women who keep farming families running.
A University of Michigan virologist's take on the current situation
The research team from the Korea Research Institute of Chemical Technology (KRICT) led by Dr. Dowon Ahn, has made significant strides in addressing the key challenges of photoresponsive, visible light 3D printing.
Alternative proteins—meat made from plants, cultivated from animal cells, or produced via fermentation—offer consumers the foods they love made with more sustainable protein sources. To evaluate the potential of plant-based meat to reduce the environmental impacts of the food system, the Good Food Institute commissioned EarthShift Global to complete a comprehensive, ISO-certified life cycle assessment (LCA). This LCA is the most comprehensive, open-access LCA conducted to date (2024).
Zymo Research Corporation, a global leader in innovative life science solutions, is proud to sponsor the Microbes in Wastewater: Antibiotic Resistance, Public Health, and Climate Change Symposium taking place January 16-17, 2025, in Newport Beach, California. This pivotal event will convene top researchers, industry experts, and public health professionals to explore the latest advancements in wastewater surveillance and its critical impact on public health, antibiotic resistance, and environmental sustainability.
PharmassêtX Inc., a late-preclinical stage pharmaceutical development company, today announced that the US Patent and Trademark Office has acknowledged receipt of the Company's patent application entitled "CRYSTALLINE FORM OF EPIGALLOCATECHIN-3-GALLATE." PharmassêtX is developing the novel form of epigallocatechin gallate (EGCG) as a prescription drug for the treatment of inflammatory bowel disease (IBD).
A recent study highlights the health benefits of a cocoa-flavored, soy-based powder drink mix enriched with hydrolysates from edible bird’s nests. This innovative functional beverage shows promise in managing hypertension and inflammation, along with improving glycemic control and prolonging satiety. The study focuses on the drink’s angiotensin-converting enzyme (ACE) inhibition and red blood cell membrane stabilization effects, suggesting a fresh approach to dietary management of chronic health issues.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
